Antimicrobici

ELQ-300 is a potent antimalarial compound, which is a synthetic quinolone derivative. As a product of chemical synthesis and medicinal chemistry, it targets the electron transport chain in the mitochondrial cytochrome bc1 complex. This compound acts by selectively inhibiting the cytochrome bc1 complex, a critical component of the parasite's mitochondrial respiratory chain, thus preventing ATP synthesis and ultimately leading to the death of the parasite.

Please enquire for more information about ML303 including the price, delivery time and more detailed product information at the technical inquiry form on this page

BRL 42715 is an antibacterial agent, which is a synthetic compound with a unique mechanism of action. This compound is derived from rational drug design aimed at targeting specific bacterial enzymes critical for cell wall synthesis. By irreversibly inhibiting these enzymes, BRL 42715 disrupts the bacterial cell wall formation, leading to cell lysis and death.

Anhydro erythromycin A is a semi-synthetic derivative of erythromycin A, which has been shown to be an effective inhibitor of bacterial growth, showing higher selectivity for this inhibition. It is a prodrug that is activated by acid catalysis and can be used as a substitute against methicillin-resistant staphylococcus. Anhydro erythromycin A was developed with the goal of increasing its stability and its potency against methicillin-resistant Staphylococcus aureus, which has been shown to be resistant to erythromycin.

Chlortetracycline-13C-d3 hydrochloride is a stable isotope-labeled antibiotic with action on bacterial protein synthesis inhibition and is used for research in bacterial resistance and analytical studies.

Imipenem acts as an antimicrobial through inhibiting cell wall synthesis of various gram-positive and gram-negative bacteria. It remains very stable in the presence of beta-lactamase (both penicillinase andcephalosporinase) produced by some bacteria, and is a strong inhibitor of beta-lactamases from some gram-negative bacteria that are resistant to most beta-lactam antibiotics.

Ascomycin is an immunosuppressant macrolide lactone, which is derived from the soil bacterium *Streptomyces hygroscopicus*. It functions primarily by inhibiting the T-cell activation pathway. The mechanism involves binding to the immunophilin FKBP-12, forming a complex that inhibits the calcium-dependent phosphatase, calcineurin. This inhibition prevents the dephosphorylation and subsequent translocation of nuclear factor of activated T cells (NFAT), which is crucial for the transcription of interleukin-2 and other cytokines. Consequently, this suppresses the activation and proliferation of T-cells, which are essential components of the adaptive immune response.

Desciclovir is an antiviral agent, which is a synthetic nucleoside analog derived from guanine. Its mode of action involves the selective inhibition of viral DNA polymerase, leading to the termination of viral DNA chain elongation. By mimicking the natural substrates of the viral nucleic acid synthesis machinery, Desciclovir effectively disrupts the replication of viral genetic material, impeding the proliferation of the virus within the host cells.

Naftoxate is a synthetic ester, which is synthesized chemically from raw materials such as fatty alcohols and carboxylic acids. With its ability to reduce surface tension, Naftoxate operates as a surfactant, facilitating emulsification and dispersion of hydrophobic substances within various aqueous systems. The compound achieves this by altering the interface between liquids, enabling them to mix more effectively.

Cefazolin is a semi-synthetic, non-beta lactam antibiotic used for the treatment of a variety of bacterial infections. It inhibits cell wall synthesis by binding to one or more of penicillin-binding proteins (PBPs), which are bacterial transpeptidases that crosslink peptidoglycan strands. Cefazolin binds to PBPs present on the surface of all Gram-negative bacteria as well as many Gram-positive bacteria. It is not effective against methicillin-resistant staphylococcus and MRSA unless combined with another antibiotic such as vancomycin or flucloxacillin. A study showed that cefazolin can decrease inflammation and tumor necrosis factor-beta levels in pregnant women with systemic inflammatory disease. It has been tested in the development of an anti-inflammatory agent for use in patients with autoimmune diseases such as rheumatoid arthritis and lupus erythe.

Steffimycin B is an anthracycline antibiotic, which is a metabolite produced by certain Streptomyces species. This compound functions by intercalating into DNA, thereby inhibiting the synthesis of nucleic acids and disrupting essential cellular processes. Its mode of action involves preventing the replication and transcription of bacterial DNA, leading to cell death. Steffimycin B has been primarily explored for its antibiotic properties, particularly in research settings for its potential to combat specific bacterial infections. Additionally, its structural similarities to other anthracyclines suggest potential use in studying mechanisms of drug resistance and interactions with DNA. Further investigation may reveal additional therapeutic applications or synergistic effects in combination with other antimicrobial agents.

Please enquire for more information about Azddmec including the price, delivery time and more detailed product information at the technical inquiry form on this page

Clindamycin palmitate hydrochloride is a semisynthetic antibiotic prodrug, which is derived from the lincomycin family, originally sourced from the bacterium *Streptomyces lincolnensis*. This compound functions through its conversion into the active form, clindamycin, once inside the body. Clindamycin acts by inhibiting bacterial protein synthesis, binding to the 50S subunit of the bacterial ribosome, thereby impeding peptide chain initiation and elongation.

GSK 3532795 is an investigational antiretroviral compound, which is a synthetic small molecule designed to inhibit HIV-1 capsid function. The source of this compound is GlaxoSmithKline, a pharmaceutical company actively engaged in the development of novel therapeutic agents. GSK 3532795 functions by disrupting the HIV-1 capsid, an essential protein shell that encases the viral RNA and associated enzymes. By targeting this structure, the compound interferes with numerous stages of the viral replication cycle, including disassembly, nuclear import, and encapsidation—thereby effectively inhibiting viral replication.

(±)-Salbutamol is a racemic mixture of a beta-2 adrenergic agonist, which is synthetically derived. This compound functions primarily by selectively stimulating beta-2 adrenergic receptors, which are predominantly located on the smooth muscle cells lining the airways. The activation of these receptors leads to the relaxation of bronchial muscle tissue, resulting in bronchodilation and improved airflow.

(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[C][1,2]-oxaborol-6-yl)oxy)acetate is a novel antifungal compound derived from boron chemistry, representing a new class of therapeutic agents in the field of antifungal treatments. The compound primarily originates from the synthesis and refinement of boron-based molecular scaffolds, yielding a structure capable of disrupting fungal growth through a unique mode of action. It functions by inhibiting the fungal enzyme leucyl-tRNA synthetase, which is crucial in protein synthesis and thus vital for fungal cell survival and proliferation. By targeting this specific enzyme, the compound effectively halts the production of essential proteins, leading to the cessation of fungal growth and eventual cell death. The primary application of this compound is in the treatment of a range of fungal infections, particularly those that are resistant to conventional antifungal drugs, offering a potent alternative in clinical settings. The application of this compound spans both topical and systemic treatments, addressing a critical need for more effective antifungal therapies.

Haloxyfop-phenol is a selective herbicide, which is a synthetic chemical compound derived from aryloxyphenoxypropionate. It acts as an acetyl-CoA carboxylase (ACCase) inhibitor, targeting the enzyme critical for fatty acid synthesis in grasses. This mode of action disrupts lipid production in susceptible grass species, leading to cessation of growth and eventual plant death.

Aurantimycin A is an antibiotic compound, which is a polypeptide derived from the bacterium genus *Streptomyces*, a type of Actinobacteria. This compound exhibits its mode of action through inhibition of bacterial protein synthesis, specifically by interfering with the ribosomal function, thereby preventing the growth and proliferation of susceptible bacterial strains. The potent activity of Aurantimycin A against Gram-positive bacteria makes it a crucial tool in microbial and biochemical research.